Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open Label Phase II Study on the Use of Panobinostat in Combination with Bortezomib and Dexamethasone as Induction in Multiple Myeloma Patients Candidate to High-Dose Therapy [Studio di fase II sull'uso di panobinostat associato a bortezomib e desametasone come terapia di induzione in pazienti con mieloma multiplo candidati ad una terapia ad alte dosi]

Next Previous
X
Search
Trial Profile

An Open Label Phase II Study on the Use of Panobinostat in Combination with Bortezomib and Dexamethasone as Induction in Multiple Myeloma Patients Candidate to High-Dose Therapy [Studio di fase II sull'uso di panobinostat associato a bortezomib e desametasone come terapia di induzione in pazienti con mieloma multiplo candidati ad una terapia ad alte dosi]

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bortezomib (Primary) ; Dexamethasone (Primary) ; Panobinostat (Primary)
  • Indications Multiple myeloma
  • Focus Biomarker; Therapeutic Use

    • Most Recent Events

    • 23 May 2013 Status changed from suspended to discontinued as reported by European Clinical Trials Database.
    • 02 Mar 2013 Status changed from recruiting to suspended as reported by European Clinical Trials Database.
    • 04 Jan 2013 Planned End Date (15 Oct 2018) added as reported by European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top